As of April 28, 2026, Protara Therapeutics's top three insider holders are Management Inc. Opaleye (TenPercentOwner, 1.99Mn shares), Jesse Shefferman (Ceo And President, 1.02Mn shares), Jesse Shefferman (Ceo And President, 1.02Mn shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Management Inc. Opaleye | - | 0 | 1,989,134 | 12 Sep, 2024 |
| Jesse Shefferman | Ceo And President | 1,021,832 | 0 | 27 Jan, 2026 |
| Jesse Shefferman | Ceo And President | 1,021,832 | 0 | 27 Jan, 2026 |
| Luke M Beshar | - | 198,000 | 0 | 05 Jul, 2022 |
| Management Inc. Opaleye | - | 0 | 130,000 | 30 Dec, 2022 |
| Jacqueline Zummo | Chief Rd Officer | 95,961 | 0 | 02 Apr, 2026 |
| Jacqueline Zummo | Chief Rd Officer | 94,827 | 0 | 09 Apr, 2026 |
| Leonardo Viana Nicacio | Chief Medical Officer | 78,181 | 0 | 21 Jan, 2026 |
| William Conkling | Chief Commercial Officer | 76,000 | 0 | 21 Jan, 2026 |
| Patrick Fabbio | Chief Financial Officer | 64,115 | 0 | 27 Jan, 2026 |
| Jathin Bandari | Chief Medical Officer | 56,704 | 0 | 23 Jan, 2024 |
| Richard S Levy | - | 51,000 | 0 | 19 May, 2025 |
| Hannah Fry | Vp, Controller | 42,723 | 0 | 27 Jan, 2026 |
| Blaine Davis | Chief Financial Officer | 20,662 | 0 | 19 Jul, 2022 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 08 Apr, 2026 | Jacqueline Zummo | Common Stock | D | 1,134 | $5.40 | 94,827 | D | S |
| 01 Apr, 2026 | Jacqueline Zummo | Common Stock | D | 22,598 | $5.26 | 95,961 | D | S |
| 01 Apr, 2026 | Jacqueline Zummo | Common Stock | D | 22,598 | $5.26 | 95,961 | D | S |
| 26 Jan, 2026 | Jacqueline Zummo | Common Stock | D | 3,724 | $6.67 | 118,559 | D | F |
| 26 Jan, 2026 | Jesse Shefferman | Common Stock | D | 8,732 | $6.67 | 1,021,832 | D | F |
| 26 Jan, 2026 | Patrick Fabbio | Common Stock | D | 3,261 | $6.67 | 64,115 | D | F |
| 26 Jan, 2026 | Jacqueline Zummo | Common Stock | D | 3,724 | $6.67 | 118,559 | D | F |
| 26 Jan, 2026 | Jesse Shefferman | Common Stock | D | 8,732 | $6.67 | 1,021,832 | D | F |
| 26 Jan, 2026 | Hannah Fry | Common Stock | D | 1,457 | $6.67 | 42,723 | D | F |
| 20 Jan, 2026 | Jesse Shefferman | Common Stock | D | 16,322 | $5.60 | 1,030,564 | D | F |
| 20 Jan, 2026 | Hannah Fry | Common Stock | D | 2,132 | $5.60 | 44,180 | D | F |
| 20 Jan, 2026 | Jacqueline Zummo | Common Stock | D | 6,578 | $5.60 | 122,283 | D | F |
| 20 Jan, 2026 | Jesse Shefferman | Common Stock | D | 16,322 | $5.60 | 1,030,564 | D | F |
| 20 Jan, 2026 | Patrick Fabbio | Common Stock | D | 3,063 | $5.60 | 67,376 | D | F |
| 20 Jan, 2026 | Jacqueline Zummo | Common Stock | D | 6,578 | $5.60 | 122,283 | D | F |
| 16 Jan, 2026 | Jacqueline Zummo | Common Stock | A | 30,000 | $0.00 | 128,861 | D | A |
| 16 Jan, 2026 | Jesse Shefferman | Common Stock | A | 87,000 | $0.00 | 1,046,886 | D | A |
| 16 Jan, 2026 | Jesse Shefferman | Common Stock | A | 87,000 | $0.00 | 1,046,886 | D | A |
| 16 Jan, 2026 | Patrick Fabbio | Common Stock | A | 28,000 | $0.00 | 70,439 | D | A |
| 16 Jan, 2026 | Hannah Fry | Common Stock | A | 9,500 | $0.00 | 46,312 | D | A |